Options: Show MedDRA Preferred Terms
Side effect | Data for drug | Placebo | Labels | |||||
---|---|---|---|---|---|---|---|---|
1 | 2 | 3 | 4 | 5 | 6 | |||
Nervousness | 8.5% - 31.1% | x | x | x | x | x | x | |
Tremor | 7.8% - 38% | x | x | x | x | x | x | |
Drowsiness | 8.2% - 14.4% | x | x | x | x | |||
Headache | 3.3% - 9.8% | x | x | x | x | x | x | |
Palpitations | 5% - 29.5% | x | x | x | x | x | x | |
Somnolence | 5.5% | x | x | |||||
Dizziness | 1.3% - 10.2% | x | x | x | x | x | x | |
Injection site pain | 0.5% - 2.6% | x | x | x | x | |||
Nausea | 1.3% - 11.5% | x | x | x | x | x | x | |
Ventricular extrasystoles | 1.5% | x | x | |||||
Insomnia | 1.5% | x | x | |||||
Asthenia | 0.5% - 2.6% | x | x | x | x | x | x | |
Tachycardia | 0% - 3.5% | x | x | x | x | x | x | |
Vomiting | 1.3% - 11.5% | x | x | x | x | x | x | |
Chest discomfort | 0% - 2.6% | x | x | x | x | |||
Anxiety | 1% | x | x | x | x | x | ||
Dry mouth | 0.5% - 1.5% | x | x | x | x | x | ||
Dyspnoea | 0% - 2% | x | x | x | x | |||
Rash | x | x | ||||||
Flushing | 0% - 2.4% | x | x | x | x | |||
Hallucination | x | x | ||||||
Cramp muscle | x | x | x | x | x | |||
Hypertonia | x | x | ||||||
Paraesthesia | x | x | ||||||
Sweating | 0% - 2.4% | x | x | x | x | x | x | |
Allergic cutaneous angiitis | x | x | x | x | x |
Information about indications was extracted from the indications and usage sections of the labels.
standard – alternative
100% | ||
75% | ||
50% | ||
10% | ||
frequent (1% to 100%) | ||
infrequent (0.1% to 1%) | ||
rare (<0.1%) | ||
postmarketing | ||
0% | ||
no frequency information | ||
not found on label |